GIACOMINI, ELISA
 Distribuzione geografica
Continente #
EU - Europa 103
NA - Nord America 66
AS - Asia 8
Totale 177
Nazione #
IT - Italia 90
US - Stati Uniti d'America 66
CN - Cina 4
DE - Germania 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
FR - Francia 2
GB - Regno Unito 2
IE - Irlanda 2
JP - Giappone 2
BG - Bulgaria 1
ES - Italia 1
Totale 177
Città #
Bologna 35
Palermo 22
Mistretta 19
Fairfield 9
Houston 9
Santa Cruz 6
Ashburn 3
Boardman 3
Rome 3
Seattle 3
Buffalo 2
Chicago 2
Dublin 2
Naples 2
Paris 2
Rovellasca 2
Sint-Niklaas 2
Cambridge 1
Grossmuehlingen 1
Kenmore 1
Las Vegas 1
Los Angeles 1
Madrid 1
Milpitas 1
Minatomirai 1
Miura 1
Montegaldella 1
Mordano 1
New York 1
Phoenix 1
Provo 1
Ravenna 1
Reston 1
San Francisco 1
Sant'ilario D'enza 1
Sofia 1
Woodbridge 1
Totale 146
Nome #
A natural-like synthetic small molecule impairs bcr-abl signaling cascades and induces megakaryocyte differentiation in erythroleukemia cells, file e1dcb334-a439-7715-e053-1705fe0a6cc9 83
Effects of trans-stilbene and terphenyl compounds on different strains of Leishmania and on cytokines production from infected macrophages, file e1dcb331-0647-7715-e053-1705fe0a6cc9 60
null, file e1dcb334-5af5-7715-e053-1705fe0a6cc9 11
Synthesis of natural urolithin M6, a galloflavin mimetic, as a potential inhibitor of lactate dehydrogenase A, file e1dcb32e-e180-7715-e053-1705fe0a6cc9 5
null, file e1dcb334-62bc-7715-e053-1705fe0a6cc9 5
null, file e1dcb334-861b-7715-e053-1705fe0a6cc9 5
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors, file e1dcb330-8443-7715-e053-1705fe0a6cc9 4
Rad51/Brca2 Disruptors Inhibit Homologous Recombination and Synergize with Olaparib in Pancreatic Cancer Cells, file e1dcb332-688e-7715-e053-1705fe0a6cc9 4
null, file e1dcb334-a0a8-7715-e053-1705fe0a6cc9 2
Totale 179
Categoria #
all - tutte 362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 362


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202029 0 0 0 0 0 0 0 27 0 2 0 0
2020/202128 0 5 0 0 3 0 5 1 3 2 4 5
2021/202227 4 2 2 0 1 1 2 1 0 2 9 3
2022/202379 2 8 18 13 11 17 0 2 3 2 3 0
2023/20249 0 0 0 2 0 3 0 1 3 0 0 0
Totale 179